| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1995;60:1348-1352
© 1995 The Society of Thoracic Surgeons
Departments of Surgery and Radiology, Duke University Medical Center, Durham, North Carolina, USA
* Address reprint requests to Dr Wolfe, Duke University Medical Center, PO Box 3507, Durham, NC 27710.
Background.: The growth rate, or doubling time, of radiographically indeterminate pulmonary abnormalities is an important determinant of malignancy. Prospective calculation of doubling time, however, delays diagnosis and treatment. Positron emission tomography (PET) using the glucose analogue flouride-18 fluorode-oxyglucose (FDG) measures the enhanced glucose uptake characteristic of neoplastic cells. We postulated that if FDG activity correlates with doubling time, then PET may allow prompt diagnosis of lung cancer.
Methods.: From March 1992 to July 1993, all patients with indeterminate focal pulmonary abnormalities were eligible for FDG PET imaging. In 53 patients, serial chest radiographs or computed tomograms were available and doubling time was computed. The FDG activity within the lesion was expressed as a standardized uptake ratio.
Results.: The mean standardized uptake ratio (± SD) was 5.9 ± 2.7 in 34 patients with cancer, versus 2.0 ± 1.7 in 19 with benign disease (p < 0.001). Using a criterion of standardized uptake ratio 2.5 or greater for malignancy, the accuracy of PET was 92% (49 of 53). The standardized uptake ratio was significantly correlated with doubling time (r = –0.89; p = 0.002).
Conclusion.: These data suggest a direct relation between tumor growth and FDG uptake in lung cancer. The technique of FDG PET demonstrates exceptional accuracy and may permit prompt diagnosis of lung cancer.
This article has been cited by other articles:
|
|
 |
|
  H. Igai, N. Matsuura, S. Tarumi, S. S. Chang, N. Misaki, T. Go, S. Ishikawa, and H. Yokomise Usefulness of [18F]fluoro-2-deoxy-D-glucose positron emission tomography for predicting the World Health Organization malignancy grade of thymic epithelial tumors Eur J Cardiothorac Surg, July 1, 2011; 40(1): 143 - 145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Cosentini, P. Tarsia, M. Cazzola, and F. Blasi Treatment of difficult Gram-positive infections Thoracic Malignancies, June 28, 2010; 113 - 130. [Abstract] [Fulltext] [PDF]
|
|
|
|
|
|
 J. A. Verschakelen, W. De Wever, J. Bogaert, and S. Stroobants Imaging: staging of lung cancer Imaging, June 28, 2010; 214 - 244. [Abstract] [Fulltext] [PDF]
|
|
|
|
 |
|
 J. J. Erasmus, E. Rohren, and S. G. Swisher Prognosis and Reevaluation of Lung Cancer by Positron Emission Tomography Imaging Proceedings of the ATS, April 15, 2009; 6(2): 171 - 179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. R. Kim, D.-J. Kim, W. W. Lee, S. Jheon, and S. W. Sung The significance of maximum standardized uptake values in patients with stage I pulmonary adenocarcinoma, Eur J Cardiothorac Surg, April 1, 2009; 35(4): 712 - 717. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. J. Lee, A. Cho, B. C. Cho, M. Yun, S. K. Kim, J. Chang, J. W. Moon, I. K. Park, H. J. Choi, and J.-H. Kim High Tumor Metabolic Activity as Measured by Fluorodeoxyglucose Positron Emission Tomography Is Associated with Poor Prognosis in Limited and Extensive Stage Small-Cell Lung Cancer Clin. Cancer Res., April 1, 2009; 15(7): 2426 - 2432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Goudarzi, H. A. Jacene, and R. L. Wahl Diagnosis and Differentiation of Bronchioloalveolar Carcinoma from Adenocarcinoma with Bronchioloalveolar Components with Metabolic and Anatomic Characteristics Using PET/CT J. Nucl. Med., October 1, 2008; 49(10): 1585 - 1592. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Uesaka, Y. Demura, T. Ishizaki, S. Ameshima, I. Miyamori, M. Sasaki, Y. Fujibayashi, and H. Okazawa Evaluation of Dual-Time-Point 18F-FDG PET for Staging in Patients with Lung Cancer J. Nucl. Med., October 1, 2008; 49(10): 1606 - 1612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. I. Na, B. H. Byun, H. J. Kang, G. J. Cheon, J. S. Koh, C. H. Kim, D. H. Choe, B.-Y. Ryoo, J. C. Lee, S. M. Lim, et al. 18F-Fluoro-2-Deoxy-Glucose Uptake Predicts Clinical Outcome in Patients with Gefitinib-Treated Non-Small Cell Lung Cancer Clin. Cancer Res., April 1, 2008; 14(7): 2036 - 2041. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Hoang, L. F. Hoagland, R. E. Coleman, A. D. Coan, J. E. Herndon II, and E. F. Patz Jr Prognostic Value of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography Imaging in Patients With Advanced-Stage Non-Small-Cell Lung Carcinoma J. Clin. Oncol., March 20, 2008; 26(9): 1459 - 1464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Cronin, B. A. Dwamena, A. M. Kelly, and R. C. Carlos Solitary Pulmonary Nodules: Meta-analytic Comparison of Cross-sectional Imaging Modalities for Diagnosis of Malignancy Radiology, March 1, 2008; 246(3): 772 - 782. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Wahidi, J. A. Govert, R. K. Goudar, M. K. Gould, and D. C. McCrory Evidence for the Treatment of Patients With Pulmonary Nodules: When Is It Lung Cancer?: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 94S - 107S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Downey, T. Akhurst, M. Gonen, B. Park, and V. Rusch Fluorine-18 fluorodeoxyglucose positron emission tomographic maximal standardized uptake value predicts survival independent of clinical but not pathologic TNM staging of resected non-small cell lung cancer J. Thorac. Cardiovasc. Surg., June 1, 2007; 133(6): 1419 - 1427. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. A. Weber, J. Czernin, and M. E. Phelps Prognostic Significance of Fluorodeoxyglucose Uptake in Non-Small Cell Lung Cancer. A Blurry Picture? Clin. Cancer Res., June 1, 2007; 13(11): 3105 - 3106. [Full Text] [PDF]
|
|
|
|
|
|
K.-H. Lee, S.-H. Lee, D.-W. Kim, W. J. Kang, J.-K. Chung, S.-A. Im, T.-Y. Kim, Y. W. Kim, Y.-J. Bang, and D. S. Heo High fluorodeoxyglucose uptake on positron emission tomography in patients with advanced non-small cell lung cancer on platinum-based combination chemotherapy. Clin. Cancer Res., July 15, 2006; 12(14): 4232 - 4236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Howard, R. Furumai, M. J. Campa, Z. N. Rabbani, Z. Vujaskovic, X.-F. Wang, and E. F. Patz Jr. Stable RNA Interference-Mediated Suppression of Cyclophilin A Diminishes Non-Small-Cell Lung Tumor Growth In vivo Cancer Res., October 1, 2005; 65(19): 8853 - 8860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Lindell, T. E. Hartman, S. J. Swensen, J. R. Jett, D. E. Midthun, M. A. Nathan, and V. J. Lowe Lung Cancer Screening Experience: A Retrospective Review of PET in 22 Non-Small Cell Lung Carcinomas Detected on Screening Chest CT in a High-Risk Population Am. J. Roentgenol., July 1, 2005; 185(1): 126 - 131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. C. Detterbeck, J. F. Vansteenkiste, D. E. Morris, C. A. Dooms, A. H. Khandani, and M. A. Socinski Seeking a Home for a PET, Part 3: Emerging Applications of Positron Emission Tomography Imaging in the Management of Patients With Lung Cancer Chest, November 1, 2004; 126(5): 1656 - 1666. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Schrevens, N. Lorent, C. Dooms, and J. Vansteenkiste The Role of PET Scan in Diagnosis, Staging, and Management of Non-Small Cell Lung Cancer Oncologist, November 1, 2004; 9(6): 633 - 643. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Buck, G. Glatting, and S. N. Reske Quantification of 18F-FDG Uptake in Non-Small Cell Lung Cancer: A Feasible Prognostic Marker? J. Nucl. Med., August 1, 2004; 45(8): 1274 - 1276. [Full Text] [PDF]
|
|
|
|
|
|
E. M. Kamel, D. Zwahlen, M. T. Wyss, K. D. Stumpe, G. K. von Schulthess, and H. C. Steinert Whole-Body 18F-FDG PET Improves the Management of Patients with Small Cell Lung Cancer J. Nucl. Med., December 1, 2003; 44(12): 1911 - 1917. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Reed General thoracic surgery and the Southern Thoracic Surgical Association: the second 25 years Ann. Thorac. Surg., November 1, 2003; 76(90050): S14 - 16. [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Gould, G. D. Sanders, P. G. Barnett, C. E. Rydzak, C. C. Maclean, M. B. McClellan, and D. K. Owens Cost-Effectiveness of Alternative Management Strategies for Patients with Solitary Pulmonary Nodules Ann Intern Med, May 6, 2003; 138(9): 724 - 735. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Demura, T. Tsuchida, T. Ishizaki, S. Mizuno, Y. Totani, S. Ameshima, I. Miyamori, M. Sasaki, and Y. Yonekura 18F-FDG Accumulation with PET for Differentiation Between Benign and Malignant Lesions in the Thorax J. Nucl. Med., April 1, 2003; 44(4): 540 - 548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Downey, T. Akhurst, D. Ilson, R. Ginsberg, M. S. Bains, M. Gonen, H. Koong, M. Gollub, B. D. Minsky, M. Zakowski, et al. Whole Body 18FDG-PET and the Response of Esophageal Cancer to Induction Therapy: Results of a Prospective Trial J. Clin. Oncol., February 1, 2003; 21(3): 428 - 432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Hollings and P. Shaw Diagnostic imaging of lung cancer Eur. Respir. J., April 1, 2002; 19(4): 722 - 742. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. A. Nabi and J. M. Zubeldia Clinical Applications of 18F-FDG in Oncology J. Nucl. Med. Technol., March 1, 2002; 30(1): 3 - 9. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Higashi, Y. Ueda, Y. Arisaka, T. Sakuma, Y. Nambu, M. Oguchi, H. Seki, S. Taki, H. Tonami, and I. Yamamoto 18F-FDG Uptake as a Biologic Prognostic Factor for Recurrence in Patients with Surgically Resected Non-Small Cell Lung Cancer J. Nucl. Med., January 1, 2002; 43(1): 39 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Higashi, Y. Ueda, T. Sakuma, H. Seki, M. Oguchi, M. Taniguchi, S. Taki, H. Tonami, S. Katsuda, and I. Yamamoto Comparison of [18F]FDG PET and 201Tl SPECT in Evaluation of Pulmonary Nodules J. Nucl. Med., October 1, 2001; 42(10): 1489 - 1496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Imdahl, S. Jenkner, I. Brink, E. Nitzsche, E. Stoelben, E. Moser, and J. Hasse Validation of FDG positron emission tomography for differentiation of unknown pulmonary lesions Eur J Cardiothorac Surg, August 1, 2001; 20(2): 324 - 329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Gambhir, J. Czernin, J. Schwimmer, D. H. S. Silverman, R. E. Coleman, and M. E. Phelps A Tabulated Summary of the FDG PET Literature J. Nucl. Med., May 1, 2001; 42(90050): 1S - 93. [Full Text] [PDF]
|
|
|
|
|
|
J.F. Vansteenkiste and S.G. Stroobants The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology Eur. Respir. J., April 1, 2001; 17(4): 802 - 820. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Gould, C. C. Maclean, W. G. Kuschner, C. E. Rydzak, and D. K. Owens Accuracy of Positron Emission Tomography for Diagnosis of Pulmonary Nodules and Mass Lesions: A Meta-analysis JAMA, February 21, 2001; 285(7): 914 - 924. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Pacak, W. M. Linehan, G. Eisenhofer, M. M. Walther, and D. S. Goldstein Recent Advances in Genetics, Diagnosis, Localization, and Treatment of Pheochromocytoma Ann Intern Med, February 20, 2001; 134(4): 315 - 329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Vesselle, R. A. Schmidt, J. M. Pugsley, M. Li, S. G. Kohlmyer, E. Vallieres, and D. E. Wood Lung Cancer Proliferation Correlates with [F-18]Fluorodeoxyglucose Uptake by Positron Emission Tomography Clin. Cancer Res., October 1, 2000; 6(10): 3837 - 3844. [Abstract] [Full Text]
|
|
|
|
|
|
K. Dhital, C. A. B. Saunders, P. T. Seed, M. J. O'Doherty, and J. Dussek [18F]Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer Eur J Cardiothorac Surg, October 1, 2000; 18(4): 425 - 428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. OST and A. FEIN Evaluation and Management of the Solitary Pulmonary Nodule Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 782 - 787. [Full Text] [PDF]
|
|
|
|
|
|
V. J. Lowe, J. H. Boyd, F. R. Dunphy, H. Kim, T. Dunleavy, B. T. Collins, D. Martin, B. C. Stack Jr, C. Hollenbeak, and J. W. Fletcher Surveillance for Recurrent Head and Neck Cancer Using Positron Emission Tomography J. Clin. Oncol., February 1, 2000; 18(3): 651 - 651. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Sakurai, N. Mitsuhashi, K. Hayakawa, and H. Niibe Giant Cell Tumor of the Thoracic Spine Simulating Mediastinal Neoplasm AJNR Am. J. Neuroradiol., October 1, 1999; 20(9): 1723 - 1726. [Abstract] [Full Text]
|
|
|
|
|
|
J. F. Vansteenkiste, S. G. Stroobants, P. J. Dupont, P. R. De Leyn, E. K. Verbeken, G. J. Deneffe, L. A. Mortelmans, and M. G. Demedts Prognostic Importance of the Standardized Uptake Value on 18F-Fluoro-2-Deoxy-Glucose–Positron Emission Tomography Scan in Non–Small-Cell Lung Cancer: An Analysis of 125 Cases J. Clin. Oncol., October 1, 1999; 17(10): 3201 - 3206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A.B. Saunders, J. E. Dussek, M. J. O'Doherty, and M. N. Maisey Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer Ann. Thorac. Surg., March 1, 1999; 67(3): 790 - 797. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. J Lowe and K. S Naunheim Current role of positron emission tomography in thoracic oncology Thorax, August 1, 1998; 53(8): 703 - 712. [Full Text]
|
|
|
|
|
|
V. J. Lowe and K. S. Naunheim Positron Emission Tomography in Lung Cancer Ann. Thorac. Surg., June 1, 1998; 65(6): 1821 - 1829. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
